SeekingBiotech2023-02-21 22:07
$Karyopharm(KPTI)$
KPTI Receives Full Marketing Authorization from MHRA for NEXPOVIO (selinexor) in Combination with Bortezomib and Dexamethasone for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy查看全文
牛唐2022-12-13 12:49
医药板块速评(2022.12.12)
1、$Fate Therapeutics(FATE)、$艾切托(ACET)、$Affimed(AFMD)等细胞疗法暴跌,是否有抄底机会?
2、$Karyopharm(KPTI) 暴跌,是否有配置机会? $特斯拉
3、$阿里巴巴-SW(09988)$ 、$葛兰素史克(GSK)$ 、$Unity(U)等期权异动,后续走势如何看?$QQ$纳指100...查看全文
美股滚雪球2022-11-22 10:42
默克同意收购$Imago BioSciences(IMGO)后,利好$Karyopharm(KPTI)$ 和$Prelude(PRLD)$
在两家公司宣布这笔价值超过10亿美元的全现金交易后,Imago股价上涨逾100%。这笔交易使默克公司(Merck)得以获得一种名为bomedemstat的潜在骨髓纤维化治疗药物。
该交易将对专注于血液恶性肿瘤的生物技...查看全文
美通社2022-11-08 14:55
马萨诸塞州纽顿和意大利佛罗伦萨2022年11月5日 /美通社/ -- 开拓新型癌症疗法的商业阶段制药企业Karyopharm Therapeutics Inc.(纳斯达克股票代码:KPTI)和领先的国际私营制药公司美纳里尼集团(以下简称"美纳里尼")今天宣布,欧盟委员会已授予selinexor孤儿药产品认定,用于治疗骨髓纤...查看全文
$Karyopharm(KPTI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-055672 Act: 34 Size: 7 MB 网页链接
$Karyopharm(KPTI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-133784 Act: 34 Size: 254 KB 网页链接
$Karyopharm(KPTI)$ 8-K Current report, items 1.01, 2.03, 3.02, 7.01, and 9.01 Accession Number: 0001193125-24-133791 Act: 34 Size: 223 KB 网页链接
$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-054686 Size: 4 KB 网页链接
$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-046871 Size: 4 KB 网页链接
$Karyopharm(KPTI)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-101705 Act: 34 Size: 2 MB 网页链接
$Karyopharm(KPTI)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-045717 Act: 34 Size: 7 MB 网页链接
$Karyopharm(KPTI)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-045718 Act: 34 Size: 1 MB 网页链接
$Karyopharm(KPTI)$ SC TO-C Written communication relating to an issuer or third party Accession Number: 0001193125-24-089714 Act: 34 Size: 28 KB 网页链接
$Karyopharm(KPTI)$ PRE 14A Other preliminary proxy statements Accession Number: 0000950170-24-042645 Act: 34 Size: 6 MB 网页链接